142 reports of this reaction
2.5% of all DESMOPRESSIN ACETATE reports
#5 most reported adverse reaction
FATIGUE is the #5 most commonly reported adverse reaction for DESMOPRESSIN ACETATE, manufactured by Ferring Pharmaceuticals Inc.. There are 142 FDA adverse event reports linking DESMOPRESSIN ACETATE to FATIGUE. This represents approximately 2.5% of all 5,690 adverse event reports for this drug.
Patients taking DESMOPRESSIN ACETATE who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for DESMOPRESSIN ACETATE, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for DESMOPRESSIN ACETATE:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 142 FDA reports for DESMOPRESSIN ACETATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 2.5% of all adverse event reports for DESMOPRESSIN ACETATE, making it a notable side effect.
If you experience fatigue while taking DESMOPRESSIN ACETATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.